Renaissance Technologies’s Insys Therapeutics, Inc. INSY Stock Holding History

Renaissance Technologies’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-573,735	Closed	-$2.65M	–	3860
2019 Q1	$2.65M	Buy	+573,735	New	+$2.72M	﹤0.01%	2167
2017 Q3	–	Sell	-35,000	Closed	-$443K	–	3476
2017 Q2	$443K	Sell	35,000 -10,200	-23%	-$121K	﹤0.01%	2795
2017 Q1	$475K	Sell	45,200 -196,300	-81%	-$2.09M	﹤0.01%	2784
2016 Q4	$2.22M	Sell	241,500 -23,000	-9%	-$260K	﹤0.01%	2167
2016 Q3	$3.12M	Buy	264,500 +34,900	+15%	+$530K	0.01%	1926
2016 Q2	$2.97M	Buy	+229,600	New	+$3.35M	0.01%	1958
2015 Q4	–	Sell	-72,700	Closed	-$2.07M	–	3517
2015 Q3	$2.07M	Sell	72,700 -68,000	-48%	-$2.5M	﹤0.01%	1965
2015 Q2	$5.05M	Buy	140,700 +108,900	+342%	+$3.39M	0.01%	1425
2015 Q1	$924K	Buy	+31,800	New	+$841K	﹤0.01%	2350
2014 Q2	–	Sell	-274,160	Closed	-$5.68M	–	3078
2014 Q1	$5.68M	Buy	+274,160	New	+$5.44M	0.01%	1182
2013 Q4	–	Sell	-473,100	Closed	-$5.52M	–	3104
2013 Q3	$5.52M	Buy	+473,100	New	+$3.88M	0.01%	1103

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Renaissance Technologies's INSY Position: Q2 2019 in Review

Renaissance Technologies sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 573,735 shares — an estimated $2.65M sold.

Renaissance Technologies first reported a position in INSY in Q3 2013 and held it in 11 quarters. The position peaked at $5.68M in Q1 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Renaissance Technologies reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Renaissance Technologies sold 573,735 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $2.65M.
Renaissance Technologies first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 11 quarters.
Renaissance Technologies's Insys Therapeutics, Inc. position peaked at $5.68M in Q1 2014.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.